These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 35373779)

  • 1. Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine.
    Pierobon E; Sechi A; Germi L; Pezzolo E; Trevisan G; Feliciani C; Naldi L
    Ital J Dermatol Venerol; 2022 Jun; 157(3):281-282. PubMed ID: 35373779
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Gallagher MC; Haessler S; Pecoy-Whitcomb E; Bayuk J
    Allergy Asthma Proc; 2022 Jan; 43(1):37-39. PubMed ID: 34983708
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps.
    Rice SM; Ferree SD; Kourosh AS
    Cutis; 2021 Jun; 107(6):288-290. PubMed ID: 34314309
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis.
    Pienkowski MM; Pienkowski SM
    Ann Allergy Asthma Immunol; 2022 Jan; 128(1):101-103. PubMed ID: 34601091
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine.
    Watts MM; Maurer LE; Grammer LC; Saltoun CA; Stevens WW
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):215-216. PubMed ID: 34699970
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees.
    Jacobson MA; Zakaria A; Maung Z; Hart C; McCalmont TH; Fassett M; Amerson E
    Clin Infect Dis; 2022 Mar; 74(4):591-596. PubMed ID: 34086881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine.
    Caroppo F; Deotto ML; Tartaglia J; Belloni Fortina A
    Dermatol Ther; 2022 Jun; 35(6):e15434. PubMed ID: 35266259
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and Adverse Events Among Long-term Care Residents Receiving a Third COVID-19 mRNA Vaccine Booster Dose in Quebec.
    Zhang XS; Moreau A; Cruz-Santiago D; Langevin S; Nguyen QD
    JAMA Netw Open; 2022 Jul; 5(7):e2223401. PubMed ID: 35862047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    Andersson NW; Thiesson EM; Hviid A
    JAMA; 2024 Mar; 331(12):1057-1059. PubMed ID: 38407875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocarditis in Three Japanese Men After the Second mRNA-Based COVID-19 Vaccine Dose.
    Sunaga T; Tanaka M; Sone H; Onuki T; Wada D; Suzuki H
    Am J Ther; 2024 Jan-Feb 01; 31(1):e93-e96. PubMed ID: 38231587
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
    Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of cutaneous arteritis after administration of mRNA coronavirus disease 2019 vaccine.
    Iwata JI; Kanetsuna Y; Takano A; Horiuchi Y
    Dermatol Ther; 2022 Aug; 35(8):e15618. PubMed ID: 35661518
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.
    Bloomfield M; Parackova Z; Hanzlikova J; Lastovicka J; Sediva A
    J Clin Immunol; 2022 Feb; 42(2):266-269. PubMed ID: 34718945
    [No Abstract]   [Full Text] [Related]  

  • 16. Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    Wolfson AR; Freeman EE; Blumenthal KG
    JAMA; 2022 May; 327(17):1702-1703. PubMed ID: 35420647
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    Weiss SR
    JAMA; 2022 May; 327(20):2019-2020. PubMed ID: 35608592
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute gastric and non-mesenteric colonic infarction following mRNA COVID-19 vaccination.
    Lee TG; Kim DH; Yun HY; Ryu DH
    Asian J Surg; 2022 Jul; 45(7):1469-1470. PubMed ID: 35618584
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    Oster ME; Shay DK; Shimabukuro TT
    JAMA; 2022 May; 327(20):2020-2021. PubMed ID: 35608588
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination.
    Rikitake S; Kokubu H; Yamamoto B; Manabe T; Fujimoto N
    Clin Exp Dermatol; 2022 Nov; 47(11):2022-2024. PubMed ID: 35699624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.